Mendelian randomisation found no causal link between GLP-1 receptor and seven mental disorders; a meta-analysis of clinical studies found no difference with GLP-1RA use in suicidality, anxiety or depressive symptoms, but a difference in eating disorders (SMD -0.71).
Meta-analysis
Ouyang et al. Causal association between glucagon-like peptide-1 receptor agonists and mental disorders: insight from genetic and real-world evidence